Palazzo Elisabetta, Kellett Meghan D, Cataisson Christophe, Bible Paul W, Bhattacharya Shreya, Sun Hong-Wei, Gormley Anna C, Yuspa Stuart H, Morasso Maria I
Laboratory of Skin Biology, NIAMS, NIH, Bethesda, MD 20892, USA.
Laboratory of Cancer Biology and Genetics, NCI, NIH, Bethesda, MD 20892, USA.
Cell Death Differ. 2017 Apr;24(4):717-730. doi: 10.1038/cdd.2017.5. Epub 2017 Feb 10.
Epidermal homeostasis relies on a well-defined transcriptional control of keratinocyte proliferation and differentiation, which is critical to prevent skin diseases such as atopic dermatitis, psoriasis or cancer. We have recently shown that the homeobox transcription factor DLX3 and the tumor suppressor p53 co-regulate cell cycle-related signaling and that this mechanism is functionally involved in cutaneous squamous cell carcinoma development. Here we show that DLX3 expression and its downstream signaling depend on protein kinase C α (PKCα) activity in skin. We found that following 12-O-tetradecanoyl-phorbol-13-acetate (TPA) topical treatment, DLX3 expression is significantly upregulated in the epidermis and keratinocytes from mice overexpressing PKCα by transgenic targeting (K5-PKCα), resulting in cell cycle block and terminal differentiation. Epidermis lacking DLX3 (DLX3cKO), which is linked to the development of a DLX3-dependent epidermal hyperplasia with hyperkeratosis and dermal leukocyte recruitment, displays enhanced PKCα activation, suggesting a feedback regulation of DLX3 and PKCα. Of particular significance, transcriptional activation of epidermal barrier, antimicrobial peptide and cytokine genes is significantly increased in DLX3cKO skin and further increased by TPA-dependent PKC activation. Furthermore, when inhibiting PKC activity, we show that epidermal thickness, keratinocyte proliferation and inflammatory cell infiltration are reduced and the PKC-DLX3-dependent gene expression signature is normalized. Independently of PKC, DLX3 expression specifically modulates regulatory networks such as Wnt signaling, phosphatase activity and cell adhesion. Chromatin immunoprecipitation sequencing analysis of primary suprabasal keratinocytes showed binding of DLX3 to the proximal promoter regions of genes associated with cell cycle regulation, and of structural proteins and transcription factors involved in epidermal differentiation. These results indicate that Dlx3 potentially regulates a set of crucial genes necessary during the epidermal differentiation process. Altogether, we demonstrate the existence of a robust DLX3-PKCα signaling pathway in keratinocytes that is crucial to epidermal differentiation control and cutaneous homeostasis.
表皮稳态依赖于角质形成细胞增殖和分化的精确转录调控,这对于预防诸如特应性皮炎、银屑病或癌症等皮肤疾病至关重要。我们最近发现,同源盒转录因子DLX3和肿瘤抑制因子p53共同调节细胞周期相关信号,并且该机制在皮肤鳞状细胞癌的发展中发挥功能作用。在此我们表明,DLX3的表达及其下游信号依赖于皮肤中蛋白激酶Cα(PKCα)的活性。我们发现,通过转基因靶向过表达PKCα的小鼠(K5-PKCα)在经12-氧十四酰佛波醇-13-乙酸酯(TPA)局部处理后,表皮和角质形成细胞中DLX3的表达显著上调,导致细胞周期阻滞和终末分化。缺乏DLX3的表皮(DLX3cKO)与伴有角化过度和真皮白细胞募集的DLX3依赖性表皮增生的发展有关,其显示出增强的PKCα激活,提示DLX3和PKCα之间存在反馈调节。特别重要的是,DLX3cKO皮肤中表皮屏障、抗菌肽和细胞因子基因的转录激活显著增加,并通过TPA依赖性PKC激活进一步增加。此外,当抑制PKC活性时,我们发现表皮厚度、角质形成细胞增殖和炎性细胞浸润减少,并且PKC-DLX3依赖性基因表达特征恢复正常。独立于PKC,DLX3表达特异性调节诸如Wnt信号传导、磷酸酶活性和细胞粘附等调控网络。对原发性基底上层角质形成细胞的染色质免疫沉淀测序分析表明,DLX3与细胞周期调控相关基因以及参与表皮分化的结构蛋白和转录因子的近端启动子区域结合。这些结果表明,Dlx3可能调节表皮分化过程中所需的一组关键基因。总之,我们证明了角质形成细胞中存在强大的DLX3-PKCα信号通路,这对于表皮分化控制和皮肤稳态至关重要。